nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCB1—Mitomycin—urinary bladder cancer	0.0775	0.135	CbGbCtD
Hydrocortisone—ABCG2—Fluorouracil—urinary bladder cancer	0.0529	0.0923	CbGbCtD
Hydrocortisone—ABCG2—Carboplatin—urinary bladder cancer	0.0526	0.0917	CbGbCtD
Hydrocortisone—ABCG2—Cisplatin—urinary bladder cancer	0.045	0.0784	CbGbCtD
Hydrocortisone—ABCG2—Etoposide—urinary bladder cancer	0.0442	0.077	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—urinary bladder cancer	0.0389	0.0679	CbGbCtD
Hydrocortisone—CYP3A4—Thiotepa—urinary bladder cancer	0.0352	0.0614	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—urinary bladder cancer	0.0301	0.0525	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—urinary bladder cancer	0.0292	0.0509	CbGbCtD
Hydrocortisone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0282	0.0491	CbGbCtD
Hydrocortisone—CYP3A5—Etoposide—urinary bladder cancer	0.0245	0.0427	CbGbCtD
Hydrocortisone—CYP2C8—Etoposide—urinary bladder cancer	0.0235	0.041	CbGbCtD
Hydrocortisone—ABCB1—Gemcitabine—urinary bladder cancer	0.0223	0.0389	CbGbCtD
Hydrocortisone—ABCB1—Cisplatin—urinary bladder cancer	0.0162	0.0283	CbGbCtD
Hydrocortisone—ABCB1—Etoposide—urinary bladder cancer	0.0159	0.0278	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—urinary bladder cancer	0.0109	0.0189	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—urinary bladder cancer	0.0105	0.0183	CbGbCtD
Hydrocortisone—CYP3A4—Etoposide—urinary bladder cancer	0.00954	0.0166	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00651	0.0113	CbGbCtD
Hydrocortisone—ANXA1—prostate gland—urinary bladder cancer	0.00363	0.0589	CbGeAlD
Hydrocortisone—CYP11B2—renal system—urinary bladder cancer	0.00363	0.0589	CbGeAlD
Hydrocortisone—NR3C1—urine—urinary bladder cancer	0.00351	0.057	CbGeAlD
Hydrocortisone—ANXA1—seminal vesicle—urinary bladder cancer	0.00307	0.0498	CbGeAlD
Hydrocortisone—ANXA1—epithelium—urinary bladder cancer	0.00266	0.0433	CbGeAlD
Hydrocortisone—CYP3A4—urine—urinary bladder cancer	0.00265	0.0431	CbGeAlD
Hydrocortisone—ANXA1—smooth muscle tissue—urinary bladder cancer	0.00257	0.0417	CbGeAlD
Hydrocortisone—ANXA1—renal system—urinary bladder cancer	0.00247	0.0401	CbGeAlD
Hydrocortisone—ANXA1—urethra—urinary bladder cancer	0.00243	0.0394	CbGeAlD
Hydrocortisone—SHBG—prostate gland—urinary bladder cancer	0.00242	0.0393	CbGeAlD
Hydrocortisone—ANXA1—female reproductive system—urinary bladder cancer	0.00198	0.0321	CbGeAlD
Hydrocortisone—ANXA1—vagina—urinary bladder cancer	0.00179	0.0291	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—urinary bladder cancer	0.0017	0.0276	CbGeAlD
Hydrocortisone—SLCO1A2—renal system—urinary bladder cancer	0.00137	0.0223	CbGeAlD
Hydrocortisone—ABCG2—prostate gland—urinary bladder cancer	0.00137	0.0222	CbGeAlD
Hydrocortisone—SHBG—female reproductive system—urinary bladder cancer	0.00132	0.0215	CbGeAlD
Hydrocortisone—CYP3A5—prostate gland—urinary bladder cancer	0.00127	0.0206	CbGeAlD
Hydrocortisone—NR3C1—prostate gland—urinary bladder cancer	0.00126	0.0205	CbGeAlD
Hydrocortisone—SHBG—vagina—urinary bladder cancer	0.0012	0.0194	CbGeAlD
Hydrocortisone—ANXA1—lymph node—urinary bladder cancer	0.00116	0.0188	CbGeAlD
Hydrocortisone—ABCG2—seminal vesicle—urinary bladder cancer	0.00116	0.0188	CbGeAlD
Hydrocortisone—NR3C1—seminal vesicle—urinary bladder cancer	0.00107	0.0173	CbGeAlD
Hydrocortisone—CYP2C8—renal system—urinary bladder cancer	0.000959	0.0156	CbGeAlD
Hydrocortisone—NR3C1—epithelium—urinary bladder cancer	0.000926	0.015	CbGeAlD
Hydrocortisone—ABCG2—urethra—urinary bladder cancer	0.000916	0.0149	CbGeAlD
Hydrocortisone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.000892	0.0145	CbGeAlD
Hydrocortisone—CYP3A5—renal system—urinary bladder cancer	0.000865	0.014	CbGeAlD
Hydrocortisone—NR3C1—renal system—urinary bladder cancer	0.000859	0.0139	CbGeAlD
Hydrocortisone—NR3C1—urethra—urinary bladder cancer	0.000843	0.0137	CbGeAlD
Hydrocortisone—CYP2C8—female reproductive system—urinary bladder cancer	0.000768	0.0125	CbGeAlD
Hydrocortisone—CYP2C8—vagina—urinary bladder cancer	0.000694	0.0113	CbGeAlD
Hydrocortisone—NR3C1—female reproductive system—urinary bladder cancer	0.000688	0.0112	CbGeAlD
Hydrocortisone—ABCG2—vagina—urinary bladder cancer	0.000675	0.011	CbGeAlD
Hydrocortisone—ABCB1—prostate gland—urinary bladder cancer	0.000674	0.0109	CbGeAlD
Hydrocortisone—CYP3A4—renal system—urinary bladder cancer	0.000649	0.0105	CbGeAlD
Hydrocortisone—CYP3A5—vagina—urinary bladder cancer	0.000627	0.0102	CbGeAlD
Hydrocortisone—NR3C1—vagina—urinary bladder cancer	0.000622	0.0101	CbGeAlD
Hydrocortisone—ABCB1—seminal vesicle—urinary bladder cancer	0.00057	0.00926	CbGeAlD
Hydrocortisone—CYP3A4—female reproductive system—urinary bladder cancer	0.00052	0.00844	CbGeAlD
Hydrocortisone—ABCB1—epithelium—urinary bladder cancer	0.000496	0.00805	CbGeAlD
Hydrocortisone—Levonorgestrel—ESR1—urinary bladder cancer	0.000477	0.172	CrCbGaD
Hydrocortisone—ABCB1—renal system—urinary bladder cancer	0.00046	0.00746	CbGeAlD
Hydrocortisone—Fluoxymesterone—ESR1—urinary bladder cancer	0.000455	0.164	CrCbGaD
Hydrocortisone—ABCB1—urethra—urinary bladder cancer	0.000452	0.00733	CbGeAlD
Hydrocortisone—ABCG2—lymph node—urinary bladder cancer	0.000437	0.00709	CbGeAlD
Hydrocortisone—Danazol—ESR1—urinary bladder cancer	0.000435	0.157	CrCbGaD
Hydrocortisone—NR3C1—lymph node—urinary bladder cancer	0.000402	0.00653	CbGeAlD
Hydrocortisone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.00039	0.141	CrCbGaD
Hydrocortisone—ABCB1—female reproductive system—urinary bladder cancer	0.000368	0.00598	CbGeAlD
Hydrocortisone—ABCB1—vagina—urinary bladder cancer	0.000333	0.00541	CbGeAlD
Hydrocortisone—Drospirenone—PTGS2—urinary bladder cancer	0.000292	0.105	CrCbGaD
Hydrocortisone—Progesterone—ESR1—urinary bladder cancer	0.000225	0.0813	CrCbGaD
Hydrocortisone—Triamcinolone—PTGS2—urinary bladder cancer	0.000216	0.078	CrCbGaD
Hydrocortisone—ABCB1—lymph node—urinary bladder cancer	0.000215	0.0035	CbGeAlD
Hydrocortisone—Mood swings—Doxorubicin—urinary bladder cancer	0.000181	0.000771	CcSEcCtD
Hydrocortisone—Asthenia—Thiotepa—urinary bladder cancer	0.000181	0.00077	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00018	0.000767	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00018	0.000767	CcSEcCtD
Hydrocortisone—Infection—Etoposide—urinary bladder cancer	0.00018	0.000766	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—urinary bladder cancer	0.00018	0.000765	CcSEcCtD
Hydrocortisone—Pruritus—Thiotepa—urinary bladder cancer	0.000179	0.00076	CcSEcCtD
Hydrocortisone—Pain—Fluorouracil—urinary bladder cancer	0.000179	0.000759	CcSEcCtD
Hydrocortisone—Paraesthesia—Cisplatin—urinary bladder cancer	0.000178	0.000756	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000178	0.000755	CcSEcCtD
Hydrocortisone—Tachycardia—Etoposide—urinary bladder cancer	0.000177	0.000753	CcSEcCtD
Hydrocortisone—Betamethasone—PTGS2—urinary bladder cancer	0.000177	0.0639	CrCbGaD
Hydrocortisone—Skin disorder—Etoposide—urinary bladder cancer	0.000176	0.000749	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—urinary bladder cancer	0.000175	0.000746	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000175	0.000745	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—urinary bladder cancer	0.000175	0.000745	CcSEcCtD
Hydrocortisone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000175	0.000744	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000175	0.000743	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000174	0.000741	CcSEcCtD
Hydrocortisone—Anorexia—Etoposide—urinary bladder cancer	0.000173	0.000735	CcSEcCtD
Hydrocortisone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000173	0.000735	CcSEcCtD
Hydrocortisone—Decreased appetite—Cisplatin—urinary bladder cancer	0.000172	0.000732	CcSEcCtD
Hydrocortisone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000172	0.000732	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000171	0.000727	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—urinary bladder cancer	0.00017	0.000724	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—urinary bladder cancer	0.00017	0.000724	CcSEcCtD
Hydrocortisone—Hypotension—Etoposide—urinary bladder cancer	0.000169	0.000721	CcSEcCtD
Hydrocortisone—Pain—Cisplatin—urinary bladder cancer	0.000169	0.00072	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000169	0.000718	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000169	0.000718	CcSEcCtD
Hydrocortisone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000168	0.000714	CcSEcCtD
Hydrocortisone—Dizziness—Thiotepa—urinary bladder cancer	0.000167	0.00071	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000167	0.000708	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000166	0.000706	CcSEcCtD
Hydrocortisone—Urticaria—Fluorouracil—urinary bladder cancer	0.000166	0.000705	CcSEcCtD
Hydrocortisone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000165	0.000702	CcSEcCtD
Hydrocortisone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000163	0.000694	CcSEcCtD
Hydrocortisone—Paraesthesia—Etoposide—urinary bladder cancer	0.000163	0.000692	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—urinary bladder cancer	0.000163	0.000692	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000162	0.00069	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—urinary bladder cancer	0.000162	0.000688	CcSEcCtD
Hydrocortisone—Vomiting—Thiotepa—urinary bladder cancer	0.000161	0.000683	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—urinary bladder cancer	0.000159	0.000678	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—urinary bladder cancer	0.000159	0.000678	CcSEcCtD
Hydrocortisone—Rash—Thiotepa—urinary bladder cancer	0.000159	0.000677	CcSEcCtD
Hydrocortisone—Dermatitis—Thiotepa—urinary bladder cancer	0.000159	0.000676	CcSEcCtD
Hydrocortisone—Headache—Thiotepa—urinary bladder cancer	0.000158	0.000673	CcSEcCtD
Hydrocortisone—Decreased appetite—Etoposide—urinary bladder cancer	0.000158	0.00067	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000157	0.000666	CcSEcCtD
Hydrocortisone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000157	0.000665	CcSEcCtD
Hydrocortisone—Fatigue—Etoposide—urinary bladder cancer	0.000156	0.000665	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000156	0.000664	CcSEcCtD
Hydrocortisone—Pain—Etoposide—urinary bladder cancer	0.000155	0.000659	CcSEcCtD
Hydrocortisone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000154	0.000654	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000154	0.000654	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—urinary bladder cancer	0.000154	0.000653	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000153	0.00065	CcSEcCtD
Hydrocortisone—Asthenia—Gemcitabine—urinary bladder cancer	0.000152	0.000648	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—urinary bladder cancer	0.000151	0.00064	CcSEcCtD
Hydrocortisone—Pruritus—Gemcitabine—urinary bladder cancer	0.00015	0.000639	CcSEcCtD
Hydrocortisone—Nausea—Thiotepa—urinary bladder cancer	0.00015	0.000638	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—urinary bladder cancer	0.00015	0.000636	CcSEcCtD
Hydrocortisone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000149	0.000635	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000148	0.000631	CcSEcCtD
Hydrocortisone—Pruritus—Fluorouracil—urinary bladder cancer	0.000148	0.000628	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000148	0.000627	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—urinary bladder cancer	0.000148	0.000627	CcSEcCtD
Hydrocortisone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000146	0.00062	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—urinary bladder cancer	0.000146	0.000619	CcSEcCtD
Hydrocortisone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000145	0.000618	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000145	0.000615	CcSEcCtD
Hydrocortisone—Urticaria—Etoposide—urinary bladder cancer	0.000144	0.000613	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000144	0.000612	CcSEcCtD
Hydrocortisone—Abdominal pain—Etoposide—urinary bladder cancer	0.000143	0.00061	CcSEcCtD
Hydrocortisone—Body temperature increased—Etoposide—urinary bladder cancer	0.000143	0.00061	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000143	0.000608	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—urinary bladder cancer	0.000143	0.000608	CcSEcCtD
Hydrocortisone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000143	0.000608	CcSEcCtD
Hydrocortisone—Asthenia—Cisplatin—urinary bladder cancer	0.000142	0.000604	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000141	0.000598	CcSEcCtD
Hydrocortisone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000138	0.000587	CcSEcCtD
Hydrocortisone—Dizziness—Fluorouracil—urinary bladder cancer	0.000138	0.000587	CcSEcCtD
Hydrocortisone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000135	0.000576	CcSEcCtD
Hydrocortisone—Vomiting—Gemcitabine—urinary bladder cancer	0.000135	0.000574	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000135	0.000573	CcSEcCtD
Hydrocortisone—Mental disorder—Methotrexate—urinary bladder cancer	0.000134	0.00057	CcSEcCtD
Hydrocortisone—Rash—Gemcitabine—urinary bladder cancer	0.000134	0.000569	CcSEcCtD
Hydrocortisone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000134	0.000569	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—urinary bladder cancer	0.000134	0.000569	CcSEcCtD
Hydrocortisone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000134	0.000568	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—urinary bladder cancer	0.000133	0.000566	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—urinary bladder cancer	0.000133	0.000566	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000133	0.000566	CcSEcCtD
Hydrocortisone—Headache—Gemcitabine—urinary bladder cancer	0.000133	0.000566	CcSEcCtD
Hydrocortisone—Vomiting—Fluorouracil—urinary bladder cancer	0.000133	0.000565	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000132	0.000563	CcSEcCtD
Hydrocortisone—Rash—Fluorouracil—urinary bladder cancer	0.000132	0.00056	CcSEcCtD
Hydrocortisone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000132	0.000559	CcSEcCtD
Hydrocortisone—Headache—Fluorouracil—urinary bladder cancer	0.000131	0.000556	CcSEcCtD
Hydrocortisone—Asthenia—Etoposide—urinary bladder cancer	0.00013	0.000553	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00013	0.000553	CcSEcCtD
Hydrocortisone—Immune system disorder—Epirubicin—urinary bladder cancer	0.000129	0.00055	CcSEcCtD
Hydrocortisone—Pruritus—Etoposide—urinary bladder cancer	0.000128	0.000546	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000128	0.000544	CcSEcCtD
Hydrocortisone—Nausea—Gemcitabine—urinary bladder cancer	0.000126	0.000536	CcSEcCtD
Hydrocortisone—Vomiting—Cisplatin—urinary bladder cancer	0.000126	0.000535	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—urinary bladder cancer	0.000125	0.000533	CcSEcCtD
Hydrocortisone—Rash—Cisplatin—urinary bladder cancer	0.000125	0.000531	CcSEcCtD
Hydrocortisone—Dermatitis—Cisplatin—urinary bladder cancer	0.000125	0.00053	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—urinary bladder cancer	0.000125	0.00053	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—urinary bladder cancer	0.000125	0.00053	CcSEcCtD
Hydrocortisone—Diarrhoea—Etoposide—urinary bladder cancer	0.000124	0.000528	CcSEcCtD
Hydrocortisone—Nausea—Fluorouracil—urinary bladder cancer	0.000124	0.000527	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000124	0.000526	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000124	0.000525	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—urinary bladder cancer	0.00012	0.00051	CcSEcCtD
Hydrocortisone—Dizziness—Etoposide—urinary bladder cancer	0.00012	0.00051	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00012	0.000508	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—urinary bladder cancer	0.00012	0.000508	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000118	0.000503	CcSEcCtD
Hydrocortisone—Nausea—Cisplatin—urinary bladder cancer	0.000118	0.0005	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000116	0.000493	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000116	0.000491	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—urinary bladder cancer	0.000115	0.00049	CcSEcCtD
Hydrocortisone—Vomiting—Etoposide—urinary bladder cancer	0.000115	0.00049	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000115	0.00049	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—urinary bladder cancer	0.000115	0.00049	CcSEcCtD
Hydrocortisone—Rash—Etoposide—urinary bladder cancer	0.000114	0.000486	CcSEcCtD
Hydrocortisone—Dermatitis—Etoposide—urinary bladder cancer	0.000114	0.000486	CcSEcCtD
Hydrocortisone—Headache—Etoposide—urinary bladder cancer	0.000114	0.000483	CcSEcCtD
Hydrocortisone—Myalgia—Methotrexate—urinary bladder cancer	0.000113	0.000482	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000113	0.000479	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—urinary bladder cancer	0.000112	0.000478	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—urinary bladder cancer	0.000112	0.000476	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—urinary bladder cancer	0.000112	0.000476	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—urinary bladder cancer	0.000112	0.000475	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00011	0.000466	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000109	0.000462	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—urinary bladder cancer	0.000108	0.000459	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—urinary bladder cancer	0.000108	0.000459	CcSEcCtD
Hydrocortisone—Nausea—Etoposide—urinary bladder cancer	0.000108	0.000458	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—urinary bladder cancer	0.000108	0.000457	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000107	0.000455	CcSEcCtD
Hydrocortisone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000107	0.000453	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—urinary bladder cancer	0.000106	0.000451	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—urinary bladder cancer	0.000106	0.000449	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—urinary bladder cancer	0.000106	0.000449	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000105	0.000448	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000105	0.000447	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—urinary bladder cancer	0.000105	0.000446	CcSEcCtD
Hydrocortisone—Malaise—Doxorubicin—urinary bladder cancer	0.000104	0.000442	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—urinary bladder cancer	0.000104	0.00044	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—urinary bladder cancer	0.000104	0.00044	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—urinary bladder cancer	0.000103	0.000439	CcSEcCtD
Hydrocortisone—Dexamethasone—PTGS2—urinary bladder cancer	0.000103	0.0372	CrCbGaD
Hydrocortisone—Oedema—Epirubicin—urinary bladder cancer	0.000102	0.000432	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000102	0.000432	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—urinary bladder cancer	0.000102	0.000432	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000101	0.000431	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—urinary bladder cancer	0.000101	0.000429	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—urinary bladder cancer	0.0001	0.000425	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—urinary bladder cancer	9.99e-05	0.000425	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—urinary bladder cancer	9.97e-05	0.000424	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—urinary bladder cancer	9.95e-05	0.000423	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—urinary bladder cancer	9.92e-05	0.000422	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.9e-05	0.000421	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—urinary bladder cancer	9.88e-05	0.00042	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—urinary bladder cancer	9.83e-05	0.000418	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—urinary bladder cancer	9.83e-05	0.000418	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—urinary bladder cancer	9.81e-05	0.000417	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—urinary bladder cancer	9.78e-05	0.000416	CcSEcCtD
Hydrocortisone—Paraesthesia—Methotrexate—urinary bladder cancer	9.76e-05	0.000415	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	9.75e-05	0.000414	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—urinary bladder cancer	9.7e-05	0.000412	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—urinary bladder cancer	9.69e-05	0.000412	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—urinary bladder cancer	9.56e-05	0.000407	CcSEcCtD
Hydrocortisone—Hypotension—Epirubicin—urinary bladder cancer	9.5e-05	0.000404	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—urinary bladder cancer	9.45e-05	0.000402	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.41e-05	0.0004	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—urinary bladder cancer	9.41e-05	0.0004	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.38e-05	0.000399	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—urinary bladder cancer	9.37e-05	0.000398	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—urinary bladder cancer	9.35e-05	0.000397	CcSEcCtD
Hydrocortisone—Pain—Methotrexate—urinary bladder cancer	9.29e-05	0.000395	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.26e-05	0.000394	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—urinary bladder cancer	9.26e-05	0.000394	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.23e-05	0.000392	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—urinary bladder cancer	9.2e-05	0.000391	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—urinary bladder cancer	9.18e-05	0.00039	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—urinary bladder cancer	9.14e-05	0.000388	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—urinary bladder cancer	9.13e-05	0.000388	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.1e-05	0.000387	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—urinary bladder cancer	8.97e-05	0.000381	CcSEcCtD
Hydrocortisone—Feeling abnormal—Methotrexate—urinary bladder cancer	8.95e-05	0.000381	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—urinary bladder cancer	8.95e-05	0.000381	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.88e-05	0.000378	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—urinary bladder cancer	8.84e-05	0.000376	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—urinary bladder cancer	8.79e-05	0.000374	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	8.78e-05	0.000373	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—urinary bladder cancer	8.77e-05	0.000373	CcSEcCtD
Hydrocortisone—Pain—Epirubicin—urinary bladder cancer	8.7e-05	0.00037	CcSEcCtD
Hydrocortisone—Urticaria—Methotrexate—urinary bladder cancer	8.63e-05	0.000367	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—urinary bladder cancer	8.59e-05	0.000365	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—urinary bladder cancer	8.59e-05	0.000365	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	8.57e-05	0.000364	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—urinary bladder cancer	8.51e-05	0.000362	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—urinary bladder cancer	8.45e-05	0.000359	CcSEcCtD
Hydrocortisone—Feeling abnormal—Epirubicin—urinary bladder cancer	8.38e-05	0.000356	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.31e-05	0.000353	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—urinary bladder cancer	8.28e-05	0.000352	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—urinary bladder cancer	8.18e-05	0.000348	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.12e-05	0.000345	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—urinary bladder cancer	8.11e-05	0.000345	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—urinary bladder cancer	8.08e-05	0.000343	CcSEcCtD
Hydrocortisone—Pain—Doxorubicin—urinary bladder cancer	8.05e-05	0.000342	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—urinary bladder cancer	8.04e-05	0.000342	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—urinary bladder cancer	8.04e-05	0.000342	CcSEcCtD
Hydrocortisone—Hypersensitivity—Methotrexate—urinary bladder cancer	8.01e-05	0.00034	CcSEcCtD
Hydrocortisone—Asthenia—Methotrexate—urinary bladder cancer	7.8e-05	0.000331	CcSEcCtD
Hydrocortisone—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.75e-05	0.00033	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.69e-05	0.000327	CcSEcCtD
Hydrocortisone—Pruritus—Methotrexate—urinary bladder cancer	7.69e-05	0.000327	CcSEcCtD
Hydrocortisone—Hypersensitivity—Epirubicin—urinary bladder cancer	7.49e-05	0.000318	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—urinary bladder cancer	7.47e-05	0.000318	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—urinary bladder cancer	7.44e-05	0.000316	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—urinary bladder cancer	7.44e-05	0.000316	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—urinary bladder cancer	7.43e-05	0.000316	CcSEcCtD
Hydrocortisone—Asthenia—Epirubicin—urinary bladder cancer	7.3e-05	0.00031	CcSEcCtD
Hydrocortisone—Pruritus—Epirubicin—urinary bladder cancer	7.19e-05	0.000306	CcSEcCtD
Hydrocortisone—Dizziness—Methotrexate—urinary bladder cancer	7.18e-05	0.000305	CcSEcCtD
Hydrocortisone—Diarrhoea—Epirubicin—urinary bladder cancer	6.96e-05	0.000296	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.93e-05	0.000295	CcSEcCtD
Hydrocortisone—Vomiting—Methotrexate—urinary bladder cancer	6.91e-05	0.000294	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—urinary bladder cancer	6.85e-05	0.000291	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—urinary bladder cancer	6.84e-05	0.000291	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—urinary bladder cancer	6.81e-05	0.000289	CcSEcCtD
Hydrocortisone—Asthenia—Doxorubicin—urinary bladder cancer	6.75e-05	0.000287	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—urinary bladder cancer	6.72e-05	0.000286	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—urinary bladder cancer	6.66e-05	0.000283	CcSEcCtD
Hydrocortisone—Vomiting—Epirubicin—urinary bladder cancer	6.46e-05	0.000275	CcSEcCtD
Hydrocortisone—Nausea—Methotrexate—urinary bladder cancer	6.45e-05	0.000274	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—urinary bladder cancer	6.44e-05	0.000274	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—urinary bladder cancer	6.41e-05	0.000273	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—urinary bladder cancer	6.41e-05	0.000272	CcSEcCtD
Hydrocortisone—Headache—Epirubicin—urinary bladder cancer	6.37e-05	0.000271	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—urinary bladder cancer	6.22e-05	0.000264	CcSEcCtD
Hydrocortisone—Nausea—Epirubicin—urinary bladder cancer	6.04e-05	0.000257	CcSEcCtD
Hydrocortisone—Vomiting—Doxorubicin—urinary bladder cancer	5.98e-05	0.000254	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—urinary bladder cancer	5.93e-05	0.000252	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—urinary bladder cancer	5.93e-05	0.000252	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—urinary bladder cancer	5.89e-05	0.000251	CcSEcCtD
Hydrocortisone—Nausea—Doxorubicin—urinary bladder cancer	5.59e-05	0.000238	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—GSTM1—urinary bladder cancer	4.43e-05	0.00035	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.37e-05	0.000344	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.35e-05	0.000343	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	4.35e-05	0.000343	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	4.35e-05	0.000343	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.33e-05	0.000342	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.28e-05	0.000337	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.25e-05	0.000335	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TYMP—urinary bladder cancer	4.24e-05	0.000335	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GPX1—urinary bladder cancer	4.24e-05	0.000335	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.21e-05	0.000333	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TYMP—urinary bladder cancer	4.21e-05	0.000332	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	4.18e-05	0.00033	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ERCC2—urinary bladder cancer	4.17e-05	0.000329	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GSTP1—urinary bladder cancer	4.15e-05	0.000328	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	4.13e-05	0.000326	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FGFR3—urinary bladder cancer	4.08e-05	0.000322	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.02e-05	0.000317	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.02e-05	0.000317	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	4e-05	0.000316	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.99e-05	0.000315	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	3.98e-05	0.000314	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ESR1—urinary bladder cancer	3.96e-05	0.000313	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.96e-05	0.000313	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—MTHFR—urinary bladder cancer	3.92e-05	0.000309	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	3.9e-05	0.000308	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.87e-05	0.000306	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.87e-05	0.000306	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TYMS—urinary bladder cancer	3.86e-05	0.000305	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.85e-05	0.000304	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NAT2—urinary bladder cancer	3.84e-05	0.000303	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—NCOR1—urinary bladder cancer	3.82e-05	0.000301	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GSTM1—urinary bladder cancer	3.82e-05	0.000301	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NAT2—urinary bladder cancer	3.8e-05	0.0003	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	3.8e-05	0.0003	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.79e-05	0.000299	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.79e-05	0.000299	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.79e-05	0.000299	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	3.76e-05	0.000297	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.75e-05	0.000296	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.7e-05	0.000292	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.69e-05	0.000291	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GPX1—urinary bladder cancer	3.66e-05	0.000288	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	3.65e-05	0.000288	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	3.65e-05	0.000288	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.64e-05	0.000287	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ERCC2—urinary bladder cancer	3.59e-05	0.000283	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	3.58e-05	0.000282	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.52e-05	0.000278	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	3.51e-05	0.000277	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CREBBP—urinary bladder cancer	3.47e-05	0.000274	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.46e-05	0.000273	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IGF1—urinary bladder cancer	3.43e-05	0.000271	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—urinary bladder cancer	3.41e-05	0.000269	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	3.38e-05	0.000267	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—MTHFR—urinary bladder cancer	3.37e-05	0.000266	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—RRM2—urinary bladder cancer	3.31e-05	0.000261	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	3.29e-05	0.00026	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—RRM2—urinary bladder cancer	3.28e-05	0.000259	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—urinary bladder cancer	3.23e-05	0.000255	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.22e-05	0.000254	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	3.18e-05	0.000251	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.18e-05	0.000251	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PPARG—urinary bladder cancer	3.17e-05	0.000251	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RHOA—urinary bladder cancer	3.14e-05	0.000248	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.12e-05	0.000246	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.12e-05	0.000246	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.11e-05	0.000245	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO2—urinary bladder cancer	3.07e-05	0.000242	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—HPGDS—urinary bladder cancer	3.07e-05	0.000242	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CREBBP—urinary bladder cancer	3.05e-05	0.000241	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO2—urinary bladder cancer	3.04e-05	0.00024	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	3.04e-05	0.00024	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.04e-05	0.00024	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.03e-05	0.000239	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTT1—urinary bladder cancer	2.98e-05	0.000235	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.95e-05	0.000233	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.94e-05	0.000232	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ERBB2—urinary bladder cancer	2.91e-05	0.00023	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.87e-05	0.000226	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.81e-05	0.000221	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.79e-05	0.00022	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL8—urinary bladder cancer	2.76e-05	0.000218	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.75e-05	0.000217	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—urinary bladder cancer	2.74e-05	0.000216	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—urinary bladder cancer	2.74e-05	0.000216	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.72e-05	0.000214	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.71e-05	0.000214	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.64e-05	0.000209	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.64e-05	0.000208	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—urinary bladder cancer	2.64e-05	0.000208	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	2.63e-05	0.000208	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CREBBP—urinary bladder cancer	2.63e-05	0.000207	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.6e-05	0.000206	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.58e-05	0.000204	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—urinary bladder cancer	2.57e-05	0.000203	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.53e-05	0.0002	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.52e-05	0.000199	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.51e-05	0.000198	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—urinary bladder cancer	2.5e-05	0.000197	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MMP9—urinary bladder cancer	2.5e-05	0.000197	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.49e-05	0.000196	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTEN—urinary bladder cancer	2.48e-05	0.000196	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.47e-05	0.000195	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.46e-05	0.000194	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	2.45e-05	0.000194	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	2.45e-05	0.000193	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.42e-05	0.000191	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.39e-05	0.000189	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.39e-05	0.000189	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.38e-05	0.000188	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.000187	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EP300—urinary bladder cancer	2.37e-05	0.000187	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.33e-05	0.000184	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.33e-05	0.000184	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	2.31e-05	0.000182	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SRC—urinary bladder cancer	2.3e-05	0.000182	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.29e-05	0.000181	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.29e-05	0.000181	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.25e-05	0.000178	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.25e-05	0.000178	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.2e-05	0.000174	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000173	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000173	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTEN—urinary bladder cancer	2.18e-05	0.000172	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.13e-05	0.000168	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000168	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.12e-05	0.000167	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.1e-05	0.000165	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.08e-05	0.000164	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.08e-05	0.000164	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—EP300—urinary bladder cancer	2.08e-05	0.000164	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.07e-05	0.000164	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTP1—urinary bladder cancer	2.06e-05	0.000163	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—urinary bladder cancer	2.06e-05	0.000163	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.06e-05	0.000162	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.04e-05	0.000161	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—urinary bladder cancer	2.02e-05	0.000159	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	1.93e-05	0.000152	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.92e-05	0.000152	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.92e-05	0.000151	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—urinary bladder cancer	1.91e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.9e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.89e-05	0.000149	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000148	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000148	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTEN—urinary bladder cancer	1.88e-05	0.000148	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.85e-05	0.000146	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.85e-05	0.000146	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.82e-05	0.000143	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.82e-05	0.000143	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.81e-05	0.000143	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000142	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000141	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—EP300—urinary bladder cancer	1.79e-05	0.000141	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.78e-05	0.000141	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.00014	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.77e-05	0.00014	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.000139	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	1.76e-05	0.000139	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.72e-05	0.000135	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—urinary bladder cancer	1.69e-05	0.000134	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	1.69e-05	0.000133	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.68e-05	0.000132	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000131	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.66e-05	0.000131	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.66e-05	0.000131	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.65e-05	0.00013	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—urinary bladder cancer	1.62e-05	0.000128	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.61e-05	0.000127	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.53e-05	0.000121	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.51e-05	0.000119	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.49e-05	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.41e-05	0.000112	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.000108	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.36e-05	0.000107	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000107	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000107	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.35e-05	0.000106	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.35e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.34e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.3e-05	0.000103	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000103	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.3e-05	0.000102	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	0.000102	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.28e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.28e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.24e-05	9.77e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	9.47e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.19e-05	9.39e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.18e-05	9.29e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	9.28e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	9.28e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.13e-05	8.89e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.12e-05	8.86e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	8.8e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	8.73e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.1e-05	8.71e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.07e-05	8.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	8.36e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	8.2e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.04e-05	8.18e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	8.09e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	8.09e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.02e-05	8.06e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.02e-05	8.06e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—urinary bladder cancer	1e-05	7.91e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.91e-06	7.82e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.81e-06	7.74e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.73e-06	7.68e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.63e-06	7.6e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	9.35e-06	7.38e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTEN—urinary bladder cancer	9.32e-06	7.35e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	9.24e-06	7.29e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	9.06e-06	7.15e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—EP300—urinary bladder cancer	8.89e-06	7.01e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.81e-06	6.95e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	8.43e-06	6.65e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	8.24e-06	6.5e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	8.1e-06	6.39e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.66e-06	6.04e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.34e-06	5.8e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.05e-06	5.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.87e-06	5.42e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.68e-06	5.27e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	6.63e-06	5.23e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.39e-06	5.04e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.37e-06	5.02e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.31e-06	4.98e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.31e-06	4.98e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.05e-06	4.77e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.94e-06	4.68e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	5.78e-06	4.56e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.78e-06	4.56e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.58e-06	4.4e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—EP300—urinary bladder cancer	5.52e-06	4.35e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.04e-06	3.98e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—EP300—urinary bladder cancer	4.8e-06	3.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.52e-06	3.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.35e-06	3.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.56e-06	2.81e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.1e-06	2.45e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.96e-06	2.34e-05	CbGpPWpGaD
